Strikingly, these toxic side effects can be overcome by an AnxA2 peptide inhibitor (TM601) or AnxA2 deficiency in mice, alleviating bleomycin-induced pulmonary inflammation and fibrosis [132,133,134]. The gene discussed is ANXA2; the disease is inflammation.